Netherlands

On October 01, 2024, the Dutch Healthcare Authority (NZa) published the second release of the 2025 DRG package (RZ25b). Three new procedure codes, four new supplementary payments (OZPs), 18 new diagnosis codes, and two new DRGs will be implemented across gastroenterology, surgery, diagnostic imaging, molecular diagnostics, and other areas.

In September 2024, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced two projects that received a subsidy under the "Subsidy scheme for promising care" in 2024 for research on the cost-effectiveness of cold plasma therapy for diabetic foot or venous leg wounds and intranasal mesenchymal stem cells in newborns with hypoxic-ischemic brain damage.

In July 2024, the Dutch Organization for Health Research and Development (ZonMw) awarded thirteen projects under the 2025 round of the Efficiency Research program, including one project on e-health, one project on extracorporeal treatments, one project in orthopedics, one project in neurology, one project in urology, two projects in obstetrics and gynecology, one project in radiotherapy and one project in the cardiovascular area.

In early July 2024, Dutch Organization for Health Research and Development (ZonMw) awarded seventeen projects under the Efficiency Research program, including four projects on e-health, two projects on diagnostic imaging techniques, two projects in orthopedics, one project on abdominal surgery, one project in gynecology, and one project in the cardiovascular area.

On July 10, 2024, the Dutch Organization for Health Research and Development (ZonMw) announced the submission of grant applications for research on patient-relevant outcomes and alternative forms of financing for innovative treatment under the Medical Specialist Care and Research (MedZO) program. The submission of grant applications will continue until October 15, 2024.

In August 2024, Dutch Organization for Health Research and Development (ZonMw) awarded four projects under the 2023 Round of the Care Evaluation and Appropriate Use program, including one project in orthopedics, one project on cardiovascular care, one project in cancer management and one project on urinary tract infection.

In the second quarter of 2024, the Dutch Healthcare Institute (ZIN) published four coverage positions on proton therapy in testicular cancer, pulmonary artery pressure remote monitoring in chronic heart failure and neuromodulation in polyneuropathy with positive recommendation for coverage under basic insurance package, and on physiotherapy and exercise therapy in primary care settings for lower back pain, which was not recommended for coverage under the basic insurance package.

On May 14, 2024, the Dutch Healthcare Authority (NZa) published another update of the 2024 Digital Care Funding Guide, which describes the possibilities for funding digital care depending on the healthcare sector, including new funding for Integrated Care Transformation Plans and the implementation of a novel platform for the assessment of innovative digital applications and/or technologies.

On May 07, 2024, the Dutch Healthcare Institute (ZIN) published the updated list of medical procedures reimbursed under basic health insurance with restrictions or limitations. The additional indications for autologous fat transplantation after a total breast removal were newly introduced to the list.

On May 01, 2024, the Dutch Healthcare Authority (NZa) published the first release of the 2025 DRG package (RZ25a). Three new procedure codes, five new supplementary payments, four new diagnosis codes and one new DRG will be implemented across gynecology, cardiology, neurology and neurosurgery, and other technology groups.

In April 2024, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced two projects which received a subsidy under the "Subsidy scheme for promising care" in 2024 for research of targeted muscle reinnervation during leg amputation and thrombectomy by catheterization in adult patients with a high-risk pulmonary embolism.

In March 2024, the Dutch Organization for Health Research and Development (ZonMw) awarded subsidies under HTA Methodology Program for 2021-2024 for five projects intended for the development of a methodology for assessing technologies used in non-curative care.